Following Binex, Vivozon illegally manufactured medicines in violation of the Pharmaceutical Affairs Act. As a result, the '1+3 Regulation Act' legislation that directly limits the number of drug became valid.

The reason was the domestic licensing system and regulatory environment in which too many generics could obtain marketing licenses. Vivozon's incident made ‘1+3 Regulation Act’ even more necessary.

According to the National Assembly and pharmaceutical industry officials on the 12th, Binex and Vivozon incidents further necessitated a legislative 1+3 Regulation Act for generics and data submission drugs.

1+3 Regulation Act was proposed by Rep. Yeong-Seok Seo (Democrat